Original article
In the interview: Prof. Dr. med. Max Geraedts, M. San., Head of the Institute for Health Services Research and Clinical Epidemiology in the Department of Medicine at the Philipps University of Marburg.
02.08.2023
If you want health regions, you have to rethink
What becomes possible with the new Section 140b “Health Regions” from the Health Care Strengthening Act. Supplemented online version
02.08.2023
Kick-off event for this year's Capital Congress 2023
02.08.2023
Roche event at HSK: “Precision oncology: progress – for everyone, a few, or for no one?”
02.08.2023
Innovation Fund Project on Mental Illnesses (RECOVER)
02.08.2023
When you talk to Marcus Quack, the DACH managing director of Revvity, and ask him what the company, which is only a few months old, actually does, he first has to take a deep breath. The company was previously affiliated with PerkinElmer, whose applied, food and enterprise services were purchased by private equity firm New Mountain Capital for nearly $2.5 billion. The new scientific solutions company Revvity, however, continues to support pharmaceutical and biotech companies as well as diagnostic laboratories, universities and governments under a new name. “Monitor Health Services Research” spoke to Marcus Quack about the company’s rather ambitious goals and a possible link to health services research.
02.08.2023
With what is now the fourth event on the topic of vaccination, “Monitor Health Services Research” is expanding its view on the one hand to European best practice approaches and, on the other hand, to very practical findings from low-threshold vaccination offers that already exist in Germany, both in pharmacies and in companies, as well as on a wider scale, but so far not too well-known field of activity of the public health service.
02.08.2023
Comment series, part 6: Prof. Dr. rer. pole. Philip Manow, Professor of Comparative Political Economy, University of Bremen